Cardiovascular disease in the elderly: current considerations

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Health Economics

Background:

• Elderly patients represent a significant portion of US healthcare costs and drug prescriptions.
• Cardiovascular disease, primarily atherosclerosis complications, is the leading cause of mortality and disability in older adults.
• Current advanced treatments for atherosclerosis are effective but costly.

Purpose of the Study:

• To highlight the economic burden of healthcare for elderly patients in the US.
• To emphasize the need for cost-effective strategies in managing cardiovascular disease in the elderly.
• To explore the potential of atherosclerosis prevention as a primary cost-reduction method.

Main Methods:

• Review of current literature on healthcare costs in the elderly.
• Analysis of the prevalence and impact of cardiovascular disease and atherosclerosis in older populations.
• Examination of existing technological interventions and their associated costs.

Main Results:

• Atherosclerosis complications account for a substantial majority of cardiovascular disease in the elderly.
• Advanced medical interventions, while beneficial, contribute significantly to healthcare expenses.
• Preventive strategies targeting atherosclerosis risk factors show promise but require further validation in elderly populations.

Conclusions:

• Prevention of atherosclerosis is the most effective cost-reduction strategy for elderly cardiovascular disease.
• Further research is essential to develop and validate specific preventive and management approaches for atherosclerosis in the elderly population.
• Addressing atherosclerosis risk factors in the elderly is crucial for improving health outcomes and managing healthcare expenditures.